The DOI matches its Crossref record; 99 of the 99 references it cites were found in a registry or an index.
Association of Fusobacterium nucleatum with immunity and molecular alterations in colorectal cancer
Open accessAbstract
The human intestinal microbiome plays a major role in human health and diseases, including colorectal cancer. Colorectal carcinogenesis represents a heterogeneous process with a differing set of somatic molecular alterations, influenced by diet, environmental and microbial exposures, and host immunity. Fusobacterium species are part of the human oral and intestinal microbiota. Metagenomic analyses have shown an enrichment of Fusobacterium nucleatum (F. nucleatum) in colorectal carcinoma tissue. Using 511 colorectal carcinomas from Japanese patients, we assessed the presence of F. nucleatum. Our results showed that the frequency of F. nucleatum positivity in the Japanese colorectal cancer was 8.6% (44/511), which was lower than that in United States cohort studies (13%). Similar to the United States studies, F. nucleatum positivity in Japanese colorectal cancers was significantly associated with microsatellite instability (MSI)-high status. Regarding the immune response in colorectal cancer, high levels of infiltrating T-cell subsets (i.e., CD3+, CD8+, CD45RO+, and FOXP3+ cells) have been associated with better patient prognosis. There is also evidence to indicate that molecular features of colorectal cancer, especially MSI, influence T-cell-mediated adaptive immunity. Concerning the association between the gut microbiome and immunity, F. nucleatum has been shown to expand myeloid-derived immune cells, which inhibit T-cell proliferation and induce T-cell apoptosis in colorectal cancer. This finding indicates that F. nucleatum possesses immunosuppressive activities by inhibiting human T-cell responses. Certain microRNAs are induced during the macrophage inflammatory response and have the ability to regulate host-cell responses to pathogens. MicroRNA-21 increases the levels of IL-10 and prostaglandin E2, which suppress antitumor T-cell-mediated adaptive immunity through the inhibition of the antigen-presenting capacities of dendritic cells and T-cell proliferation in colorectal cancer cells. Thus, emerging evidence may provide insights for strategies to target microbiota, immune cells and tumor molecular alterations for colorectal cancer prevention and treatment. Further investigation is needed to clarify the association of Fusobacterium with T-cells and microRNA expressions in colorectal cancer.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“supporting studies reporting that F nucleatum reduces the anti-tumor immune response.”
From Influence of the Gut Microbiome, Diet, and Environment on Risk of Colorectal Cancer (2020) · cites this paper as [29]
In the citing paper
“Moreover, levels of F nucleatum in tumor tissue have been associated with lower infiltration by T cells,29, 30”
From Influence of the Gut Microbiome, Diet, and Environment on Risk of Colorectal Cancer (2020) · cites this paper as [29]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
PD-1 and PD-L1 Immune Checkpoint Blockade to Treat Breast Cancer
Hartkopf, A. D., Taran, F., Wallwiener, M., Walter, C. B., Krämer, B., Grischke, E., & Brucker, S. Y. (2016) · Breast Care · doi:10.1159/000453569 · Cited by 30,989
Adverse Renal Effects of Immune Checkpoint Inhibitors: A Narrative Review
Wanchoo, R., Karam, S., Uppal, N. N., Barta, V. S., Deray, G., Devoe, C., Launay‐Vacher, V., Jhaveri, K. D., & on behalf of Cancer and Kidney International Network Workgroup on Immune Checkpoint Inhibitors (2017) · American Journal of Nephrology · doi:10.1159/000455014 · Cited by 15,320
The blockade of immune checkpoints in cancer immunotherapy
Pardoll, D. M. (2012) · Nature Reviews Cancer · doi:10.1038/nrc3239 · Cited by 13,838
PD-1 blockade induces responses by inhibiting adaptive immune resistance
Tumeh, P. C., Harview, C. L., Yearley, J. H., Shintaku, I. P., Taylor, E. J. M., Robert, L., Chmielowski, B., Spasic, M., Henry, G., Ciobanu, V., et al. (2014) · Nature · doi:10.1038/nature13954 · Cited by 6,609
Cancer Immunoediting: Integrating Immunity’s Roles in Cancer Suppression and Promotion
Schreiber, R. D., Old, L. J., & Smyth, M. J. (2011) · Science · doi:10.1126/science.1203486 · Cited by 6,474
Predictive correlates of response to the anti-PD-L1 antibody MPDL3280A in cancer patients
Herbst, R. S., Soria, J.-C., Kowanetz, M., Fine, G. D., Hamid, O., Gordon, M. S., Sosman, J. A., McDermott, D. F., Powderly, J. D., Gettinger, S. N., et al. (2014) · Nature · doi:10.1038/nature14011 · Cited by 5,231
The immune contexture in human tumours: impact on clinical outcome
Fridman, W. H., Pagès, F., Sautès-Fridman, C., & Galon, J. (2012) · Nature reviews. Cancer · doi:10.1038/nrc3245 · Cited by 4,981
Genetic Basis for Clinical Response to CTLA-4 Blockade in Melanoma
Snyder, A., Makarov, V., Merghoub, T., Yuan, J., Zaretsky, J. M., Desrichard, A., Walsh, L. A., Postow, M. A., Wong, P., Ho, T. S., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1406498 · Cited by 4,286
Nivolumab plus Ipilimumab in Advanced Melanoma
Wolchok, J. D., Kluger, H., Callahan, M. K., Postow, M. A., Rizvi, N. A., Lesokhin, A. M., Segal, N. H., Ariyan, C. E., Gordon, R.-A., Reed, K., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1302369 · Cited by 4,230
Molecular and genetic properties of tumors associated with local immune cytolytic activity
Rooney, M. S., Shukla, S. A., Wu, C. J., Getz, G., & Hacohen, N. (2015) · Cell · doi:10.1016/j.cell.2014.12.033 · Cited by 3,825
Flagged first, then by citations
Cited by
Sorted by citations
Items 301–343 of 343
Gut microbiota and the immune system: A regulatory axis through host MicroRNA modulation
Khosrojerdi, M., Azad, F. J., Haghbin, A., & Azimian, A. (2026) · Infection Genetics and Evolution · doi:10.1016/j.meegid.2026.105996 · Cited by 1
Dynamic relationships among tumor, immune response, and microbiota
Tsunoda, T., Shimada, K., Uchida, N., Kobayashi, S., & Sasaki, Y. (2017) · Trends in Immunotherapy · doi:10.24294/ti.v1.i2.79 · Cited by 1
Association of Fusobacterium nucleatum in the Progression of Colorectal Cancer
Rafique, A., & Koh, Y.-S. (2021) · Journal of Bacteriology and Virology · doi:10.4167/jbv.2021.51.2.039 · Cited by 2
Healthy gut microbiome in the prevention of colorectal cancer
Rumman, M., Nagasaka, M., Al-Share, B. A., Azmi, A. S., & Uddin, M. H. (2022) · Elsevier eBooks · doi:10.1016/b978-0-12-822238-6.00005-4 · Cited by 1
Intersecting Pathologies: Vulvar Cancer Complicated by a Fusobacterium necrophorum Infection
Anderson, T. R., Carletto, E. J., Barreto-Nadal, V., Langston, E., & Jones, M. (2024) · Cureus · doi:10.7759/cureus.73420 · Cited by 1
Characterization of Salivary Microbiota in Japanese Patients with Oral Cancer
Kumagai, K., Ishikawa, S., Iino, M., Edamatsu, K., Okuyama, N., Yusa, K., Shimizu, Y., Aoki, R., Masuda, C., Ohashi, Y., et al. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26052339 · Cited by 1
Faecal microbial profiles of Angus beef cattle with divergent immune responses
Maslen, B. N., Hine, B. C., Duff, C. J., Alexandre, P. A., Clark, S., van der Werf, J. H. J., White, J. D., & Pant, S. D. (2025) · Livestock Science · doi:10.1016/j.livsci.2025.105719 · Cited by 1
Diet, Microbiome, Inflammation, and Cancer
Zhang, X., & Daniel, C. R. (2021) · Physiology in health and disease · doi:10.1007/978-3-030-67951-4_11 · Cited by 1
Permissive/Protective Interplay of Microbiota with T Cell Adaptive Immune Response in Colon Cancer
Mojtahedi, Z., Rezaeifard, S., & Faghih, Z. (2016) · Annals of Colorectal Research · doi:10.17795/acr-43883
Nosho, K., Sukawa, Y., & Nakase, H. (2016) · PubMed · doi:10.11405/nisshoshi.113.1878
Microbiota and Colon Cancer: Orchestrating Neoplasia Through DNA Damage and Immune Dysregulation
Martín, A., & Irrazábal, T. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-801238-3.65124-3
Zong, Y., Lei, C., Cheng, X., Liao, B., Ye, X., Liu, T., Li, J., Zhou, X., Xu, W., & Ren, B. (2020) · Research Square · doi:10.21203/rs.3.rs-122131/v1
Fusobacterium nucleatum: caution with interpreting historical patient sample cohort
Johnstone, K. L. F., Toomey, S., Madden, S. F., O’Neill, B. D. P., & Hennessy, B. T. (2021) · Journal of Pathology and Translational Medicine · doi:10.4132/jptm.2021.08.27
Zong, Y., Lei, C., Xiangyun, C., Liao, B., Ye, X., Liu, T., Li, J., Zhou, X., Xu, W., & Ren, B. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.12.17.423374
Comparison of the Fecal Bacterial Microbiota between Healthy and Diarrheic Donkey FoalsPreprint
Liu, B., Jiang, G., Ge, S., Li, L., Li, M., Dong, B., Ji, C., Wang, Y., Fan, Z., & Zhao, F. (2022) · SSRN Electronic Journal · doi:10.2139/ssrn.4118225
Dai, D., Li, B., Li, M., & Cheng, L. (2023) · PubMed Central · doi:10.12182/20230160205
Jiang, Y.-J., Guo, N.-T., Xia, X.-P., Ji, Y., & Huo, J. (2023) · World Chinese Journal of Digestology · doi:10.11569/wcjd.v31.i24.1007
Overview of relationship between intestinal flora imbalance and diseases
Wang, K.-Y., & Zhong, X.-Q. (2024) · World Chinese Journal of Digestology · doi:10.11569/wcjd.v32.i4.280
Shang, H., Zhang, X., Su, H., Chen, H., Qin, N., & Chen, H. (2024) · Interdisciplinary cancer research · doi:10.1007/16833_2024_298
Filatov, A. V., Minin, A. V., & Николаев, С. В. (2025) · Agricultural science Euro-North-East · doi:10.30766/2072-9081.2025.26.2.388-395
Takahashi, G., Matsuda, A., Yamada, T., Uehara, K., Shinji, S., Yokoyama, Y., Iwai, T., Miyasaka, T., Kanaka, S., Yoshimori, D., et al. (2025) · Surgical Case Reports · doi:10.70352/scrj.cr.25-0070
The Correlation Between Fusobacterium nucleatum and Colorectal Cancer: A Comprehensive Review
Torkashvand, R., Hajikhani, B., Dadashi, M., Dabiri, H., & Doust, R. H. (2024) · International Journal of Enteric Pathogens · doi:10.34172/ijep.5672
Jin, K.-T., Chen, B., Liu, Y.-Y., Lan, H. U.-R., & Yan, J.-P. (2021) · Figshare · doi:10.6084/m9.figshare.14432549
Li, G., Sun, Y., Huang, Y., Lian, J., Wu, S., Luo, D., & Gong, H. (2023) · Figshare · doi:10.6084/m9.figshare.23118995
Li, G., Sun, Y., Huang, Y., Lian, J., Wu, S., Luo, D., & Gong, H. (2023) · Figshare · doi:10.6084/m9.figshare.23119001
Liang, Y., Zhang, Q., Yu, J., Hu, W., Xu, S., Xiao, Y., Ding, H., Zhou, J., & Chen, H. (2024) · Figshare · doi:10.6084/m9.figshare.26170615
Sambruni, G., Macandog, A. D. G., Wirbel, J., Cagnina, D., Catozzi, C., Dallavilla, T., Borgo, F., Fazio, N., Romario, U. F., Petz, W. L., et al. (2023) · Figshare · doi:10.6084/m9.figshare.22735449
Li, G., Sun, Y., Huang, Y., Lian, J., Wu, S., Luo, D., & Gong, H. (2023) · Figshare · doi:10.6084/m9.figshare.23119004
Li, G., Sun, Y., Huang, Y., Lian, J., Wu, S., Luo, D., & Gong, H. (2023) · Figshare · doi:10.6084/m9.figshare.23118998
Zhang, K., Liu, L., Wu, P., Zhao, L., Zhou, J., & Wu, Y. (2025) · Genomics · doi:10.1016/j.ygeno.2025.111186
Role of the gut microbiome in the development of colorectal cancer
Shanbhag, A. P. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-40483-2.00040-6
Evrard, D. (2023) · theses.fr (ABES) · doi:10.70675/bdde7470z307dz42bfzb795zf574ce0f1d2b
Zuo, T., Lu, Y., & Li, Y. P. (2025) · Springer handbooks · doi:10.1007/978-3-032-01636-2_37
Kanehara, R., Yamaji, T., Kameyama, K., Kuchiba, A., Kakugawa, Y., Ikematsu, H., Hotta, K., Sekiguchi, M., Kobayashi, N., Matsuda, T., et al. (2026) · Cancer Epidemiology · doi:10.1016/j.canep.2026.103134
The microbiome and its impact on the epigenome in cancer
Kapoor, A., Kumar, R., Gupta, A., Sansar, B., Mishra, B. K., Chaudhary, M., Rungta, A., Kallapura, G., & Prabhash, K. (2026) · Frontiers in Epigenetics and Epigenomics · doi:10.3389/freae.2026.1857307
Cancer and the gut microbiome: the oncogenic impact of dysbiosis
Aden, D., Darji, K., & Zaheer, S. (2026) · Surgical and Experimental Pathology · doi:10.1186/s42047-026-00244-5
Cheng, Y., 余申翰, Huang, Y., & Liu, B. (2026) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2026.103002
The Dual Face of Fusobacterium nucleatum in Cancer: Foe, Friend or Both?
Chander, A., Lim, H., Bachrach, G., & Ferreira, M. R. (2026) · Journal of Periodontal Research · doi:10.1111/jre.70165
A 3D Tumor Spheroid Platform to Model Fusobacterium nucleatum-Induced Tumorigenesis
Chen, Y.-W., Kariv, O., & Ton‐That, H. (2026) · Methods in molecular biology · doi:10.1007/978-1-0716-5388-3_14
Sarkar, P., Shannigrahi, S., Sen, O., Adak, S., Jana, P., & Manna, S. (2026) · ChemistrySelect · doi:10.1002/slct.202507043
Escudero-Jiménez, Á., Ros, J. G., Huertas-López, F., Pérez-Sarabia, A., Ribeiro, D., Postigo-Corrales, F., Albaladejo-González, A., Díaz-López, M. I., López-Abellán, M. D., García-Rodríguez, J., et al. (2026) · mSystems · doi:10.1128/msystems.00622-26
Yan, J., Ma, R., & Xi, Y. (2026) · Genes · doi:10.3390/genes17091025
Polaček, P., Fiala, V., Feldmar, D., Matějů, M., Čapoun, O., & Soukup, V. (2026) · Česká urologie · doi:10.48095/cccu2026018
Metadata
- Authors
- Nosho, K.
- Affiliations
- Sapporo Medical University (JP)
- Corresponding author
- Nosho, Katsuhiko
- Venue
- World Journal of Gastroenterology
- Publisher
- Baishideng Publishing Group Inc.
- Published
- 2016
- Volume
- 22
- Issue
- 2
- Pages
- 557
- ISSN
- 1007-9327 (ISSN-L)
- PMC
- PMC4716059
- OpenAlex
- W2298181742
- Cited by
- 344
- References
- 99
- Citations by year
- 2026: 16 · 2025: 22 · 2024: 34 · 2023: 47 · 2022: 49 · 2021: 46 · 2020: 36 · 2019: 33 · 2018: 36 · 2017: 17 · 2016: 8
- FWCI
- 2.83
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by-nc
- Locations
- World Journal of Gastroenterology (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Pancreas Research Foundation of Japan
- Japan Society for the Promotion of Science (221S0001, 25670371, 26640101)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Health Sciences › Medicine › Oncology › Cancer Immunotherapy and Biomarkers
- Health Sciences › Dentistry › Periodontics › Oral microbiology and periodontitis research
- Keywords
- Fusobacterium nucleatum, colorectal cancer, gut microbiota, microsatellite instability, antitumor immunity, T cell infiltration, immunosuppression, myeloid-derived cells, miR-21, IL-10, prostaglandin E2, dendritic cells, Japanese patients
- MeSH terms
- Gastrointestinal Microbiome, Animals, Fusobacterium Infections, Humans, Immunity, Innate, Lymphocyte Activation, Biomarkers, Tumor, Colorectal Neoplasms, T-Lymphocyte Subsets, Lymphocytes, Tumor-Infiltrating, Fusobacterium nucleatum, Tumor Escape, Microsatellite Instability, Host-Pathogen Interactions, Adaptive Immunity, Tumor Microenvironment
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
